Lecture 3 – The Biochemistry of Cognition: Breaking Alzheimer’s – The Definitive Lecture Series

I am the first and only scientist to solve the biochemical mechanism and cause of reduced cognition – a deficiency of plasmalogens in the synaptic membrane of cholinergic neurons leads to a reduced uptake of choline following a neuron firing event. Reduced synaptic choline uptake results in excessive de novo intracellular choline synthesis via methyltransferase activity (which causes elevated homocysteine) and membrane catabolism (which causes cell shrinkage) to sustain sufficient acetylcholine levels for nerve transmission. Using data from multiple independent international clinical research collaborators I published data supporting this mechanism and cause in 2007. From 2007, I developed, tested, and validated various biochemical precursor technologies capable of selectively and specifically elevating plasmalogens and was awarded multiple diagnostic and synthetic chemistry patents related to this work.  In 2021, I proved that my hypothesis was correct by administering a plasmalogen precursor that I specifically designed for improved synaptic neurotransmitter release to twenty-two persons diagnosed with cognitive impairment.  In less than four months, a statistically significant improvement in cognition was observed.  

To access the FREE seminars with full presentations and videos please visit Dr. Goodenowe’s resource site here. This is the article for Lecture 3 – The Biochemistry of Cognition: Breaking Alzheimer’s – The Definitive Lecture Series.

In Lecture #3 – The Biochemistry of Cognition of the Definitive Lecture Series, I present and explain the science so everyone can understand how cognition works, how it fails, and how and why plasmalogen supplementation works. Specifically, in the lecture, you will learn: 

  • How the prevalence and severity of cognitive decline increases with increasing age 
  • That approximately 60% of persons over 90 are cognitively impaired 
  • That reduced cognition is an independent risk factor for all-cause mortality 
  • That impaired cholinergic neuron function is a prerequisite to cognitive decline 
  • The synaptic availability of acetylcholine is directly related to and causal to cognition  
  • The density of acetylcholine neuron terminals is directly related to and causal to cognition 
  • Presynaptic neuron acetylcholine synthesis and release during neuron transmission is dependent upon sufficient local choline availability 
  • The primary source and mechanism to recharge presynaptic acetylcholine levels is choline uptake from the synapse via the choline high affinity transporter (CHT) 
  • Inhibition of the CHT dramatically reduces the ability of acetylcholine neuron to maintain stimulated acetylcholine release 
  • Reduced CHT activity initiates intracellular membrane auto-cannibalism to maintain choline availability for acetylcholine 
  • Auto-cannibalism is active in Alzheimer’s brain 
  • Ethanolamine plasmalogens have unique membrane fusion enabling properties 
  • Membrane fusion efficiency is dependent upon the concentration of DHA containing plasmalogens in the membrane 
  • Membrane fusion is the biophysical process through which CHT is expressed on presynaptic membranes 
  • That plasmalogen levels are decreased in brain samples of persons with dementia 
  • Plasmalogen deficient animals exhibit reduced acetylcholine neurotransmitter release  
  • Deficient DHA-plasmalogens in the brain is the primary cause of reduced cognition 

Cognition is and has always been of great interest to humans. A great deal of philosophical and biochemical research has been performed on this topic. However, it was not until the mid to late 1970s that specific biochemical and neuroanatomical abnormalities were directly associated with Alzheimer’s neuropathology and reduced mental function. Researchers compared the biochemical activity of different enzymes involved in the biosynthesis of different neurotransmitters. The biochemical system that was observed to be selectively impaired in Alzheimer’s disease and dementia was the acetylcholine neuron system. This discovery clarified earlier observations that anticholinergic drugs could induce dementia in the elderly in the 1960s. These observations spurred a flurry of research into the cholinergic system and its role in cognition and dementia. We now know a lot of detailed information about the acetylcholine neuron system in the brain and its role in cognition. All the reams of data accumulated since then have not changed a simple fact: reduced mental function is caused by a reduction in acetylcholine neuron transmission — period.  

I call plasmalogens the lipid of life because plasmalogens are the key to your brain’s quantum mechanical powers. The essence of your brain is the connectivity and communication of your neurons. When you verbally communicate with another person, your vocal chords transmit a sound wave. The other person receives the sound wave in their ear. This is the equivalent of two neurons talking to each other. However, neurons do not use sound waves to communicate, they use neurotransmitters. Instead of using vocal chords to create and transmit a sound wave that travels between two people in the air, neurons spit out packets of neurotransmitters that travel between two neurons in a gap between the two neurons called a synapse. The neuron doing the talking is called the presynaptic neuron and the neuron doing the listening is called the postsynaptic neuron. The talking neuron stores pre-packaged neurotransmitters in neurotransmitter containers called vesicles. When the talking neuron wants to speak, it has to spit its neurotransmitters into the synapse. This is a biophysical process where the vesicle has to fuse to the presynaptic membrane and release its contents. At this instance, the phospholipids of the membrane and the phospholipids of the vesicle must be able to mix together to form a new membrane in a process called membrane fusion. The physical process of membrane fusion involves a transition phase called an inverse hexagonal phase. One of the special powers of plasmalogens is the ease at which they can form an inverse hexagonal phase – better than any other phospholipid in the body. The formation of this phase is a prerequisite for two phospholipid bilayers to fuse into one membrane. This occurs at the very instance that a presynaptic vesicle (which contains the neurotransmitters) touches the presynaptic membrane. This is the biophysical process of neuron transmission. It is the most basic function of the brain – required of all neurons of all types. It is the biological equivalent of flipping a light switch on and off, which sounds simple enough in the abstract. It is the scale at which the brain performs these functions that is difficult to grasp. 

The human brain contains approximately 100 billion neurons. To put that in context, if each neuron were a grain of sand, the number of neurons in the brain would be roughly equal to filling a small swimming pool (10’ x 15’ x 5’) or 750 gallons with sand. Each neuron sends out 7000 dendrites that make synaptic connections with other neurons. That is seven quintillion synapses. Now, if each synapse were a grain of sand, this would be equivalent to 20 football fields (100 yards by 50 yards), all filled by about 6’ of sand. At each of the neuron terminals, the presynaptic neuron bouton contains about 130 synaptic vesicles. These vesicles contain the neurotransmitters that are released every time a neuron transmits its signal. Again, using our sand analogy, the number of vesicles is then slightly more than the total volume of concrete used to make the Hoover dam. The neuronal firing rate for the human brain ranges from 10 to >100 times per second. So, imagine every grain of sand in the Hoover dam, bursting and then reforming itself 10-100 times every second of every day of every year of your life. That is occurring in your brain as you read this. Now, let’s put this computing power in perspective. A typical high-end computer used by gamers has a clock speed of four Gigahertz — four billion events per second. The average clock speed of the human brain ranges from seven to 70 million Gigahertz. All the computers sold globally annually have approximately the combined computing power of one human brain. It is this massive quantum computing power that enables your brain to hover between reality and non-reality and your consciousness to push it one way or another through thought. 

Your brain can only maintain this level of activity if it has sufficient levels of plasmalogens in the synapse to enable the fusion of presynaptic vesicles with the synaptic membrane and release of their neurotransmitter load and sufficient levels of plasmalogens in the myelin sheath to enable signal transmission from one neuron to another. This process is the most basic of all physiological processes and common to all neurons in the human brain. It is independent of the type of neuron, neurotransmitter, or postsynaptic receptor.  

In Lecture 3 – The Biochemistry of Cognition, Dr. Goodenowe explains the relevant research and literature relating to the biochemistry of cognition. The lectures integrate Dr. Goodenowe’s own research and over 50 years of research from leading researchers from around the world. 

Share on facebook
Share on twitter
Share on linkedin
Your privacy is important to us.

To better protect your privacy, we provide this notice explaining our online information practices and the choices you can make about the way your information is collected and used. To make this notice easy to find, we make it available on our homepage and at every point where personally identifiable information may be requested.

Collection of Personal Information

When visiting drdayangoodenowe.com, the IP address used to access the site will be logged along with the dates and times of access. This information is purely used to analyze trends, administer the site, track users’ movement and gather broad demographic information for internal use. Most important, any recorded IP addresses are not linked to personally identifiable information.

Links to Third-Party Websites
We have included links on this site for your use and reference. We are not responsible for the privacy policies on these websites. You should be aware that the privacy policies of these sites may differ from our own.
Our Use of Google Analytics
The Dr. Dayan Goodenowe website uses the Google Analytics tool to measure traffic on the site and traffic to the site via our online advertising. This includes using certain Advertising Features, which enable Google Analytics to collect data about users via Google advertising cookies and identifiers, in addition to anonymous data collected through the standard Google Analytics implementation. These Advertising Features, which drdayangoodenowe.com may or may not be currently using, include:
  • Remarketing with Google Analytics. This allows us to display our ads to you as you search online for similar businesses.
  • Google Display Network Impression Reporting, which shows which of our ads users click on.
  • Google Analytics Demographics and Interest Reporting, which provides information about the age and gender of site users, along with the interests they express in their online travel and purchasing activities.
  • Integrated services that require Google Analytics to collect data via advertising cookies and identifiers.
We do not merge personally identifiable information with non-personally identifiable information collected through any Google advertising product or feature unless we have obtained robust notice of, and the user’s prior affirmative (i.e., opt-in) consent to, that merger. These Advertising Features, which drdayangoodenowe.com may or may not be currently using, include:
Opt Out

There are several ways to opt out of interest-based advertising and/or all tracking related to Google Analytics and its advertising features.

You can opt out of interest-based ads by Google through Ads Settings. When you opt out, you’ll still see ads but they may not be related to factors such as your interests, previous visits to other websites, or demographic details. Obtain instructions here.

The Network Advertising Initiative offers a free tool that allows users to opt out from receiving interest-based ads from some or all NAI participating member companies that use cookies on your computer browser to collect data for interest-based advertising. Find information about it here.

Website visitors can totally block Google Analytics with the Google Analytics opt-out browser add-on (click to download). This add-on instructs the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) running on websites to prohibit their information from being used by Google Analytics. Using the Google Analytics opt-out plug-in will not prevent site owners from using other tools to measure site analytics. Learn more about about the opt-out and how to properly install the browser add-on here.

Changes to this Privacy

Statement The contents of this statement may be altered at any time, at our discretion.

If you have any questions regarding the privacy policy of drdayangoodenowe.com then you may contact us at info@drdayangoodenowe.com

terms of use
Welcome to our website. If you continue to browse and use this website, you are agreeing to comply with and be bound by the following terms and conditions of use, which together with our privacy policy govern drdayangoodenowe.com’s relationship with you in relation to this website. If you disagree with any part of these terms and conditions, please do not use our website.

The term ‘drdayangoodenowe.com’ or ‘us’ or ‘we’ refers to the owner of the website whose registered office is:

40880 County Center Drive
Suite R
Temecula, CA 92591, USA

The term ‘you’ refers to the user or viewer of our website.

The use of this website is subject to the following terms of use:

The content of the pages of this website is for your general information and use only. It is subject to change without notice.

Neither we nor any third parties provide any warranty or guarantee as to the accuracy, timeliness, performance, completeness or suitability of the information and materials found or offered on this website for any particular purpose. You acknowledge that such information and materials may contain inaccuracies or errors and we expressly exclude liability for any such inaccuracies or errors to the fullest extent permitted by law.

Your use of any information or materials on this website is entirely at your own risk, for which we shall not be liable. It shall be your own responsibility to ensure that any products, services or information available through this website meet your specific requirements.

This website contains material which is owned by or licensed to us. This material includes, but is not limited to, the design, layout, look, appearance and graphics. Reproduction is prohibited other than in accordance with the copyright notice, which forms part of these terms and conditions.

All trademarks reproduced in this website, which are not the property of, or licensed to the operator, are acknowledged on the website.

Unauthorized use of this website may give rise to a claim for damages and/or be a criminal offence.

From time to time, this website may also include links to other websites. These links are provided for your convenience to provide further information. They do not signify that we endorse the website(s). We have no responsibility for the content of the linked website(s).

Your use of this website and any dispute arising out of such use of the website is subject to the laws of Canada and USA.

We use cookies to make this site as useful as possible. They are small text files we put in your browser to track usage of our site but they don’t tell us who you are. If you want to delete any cookies that are already on your computer, please refer to the instructions for your file management software to locate the file or directory that stores cookies.

This site is not a part of the Facebook website or Facebook Inc. Additionally, this site is not endorsed by Facebook in any way. FACEBOOK is a trademark of FACEBOOK, Inc.